Published in Nat Genet on February 01, 1998
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest (2009) 6.70
A promoter-level mammalian expression atlas. Nature (2014) 6.25
The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev (2001) 4.40
Modeling stochastic gene expression: implications for haploinsufficiency. Proc Natl Acad Sci U S A (1998) 3.49
Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev (2002) 2.98
Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol (2007) 2.78
Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet (2001) 2.32
Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain (2010) 2.19
Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol (2000) 2.11
Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet (2003) 2.10
The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res (2000) 1.91
Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. Am J Hum Genet (2003) 1.88
A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A (2000) 1.76
SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res (2001) 1.71
Multiple conserved regulatory elements with overlapping functions determine Sox10 expression in mouse embryogenesis. Nucleic Acids Res (2007) 1.68
Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog. Proc Natl Acad Sci U S A (2006) 1.61
Identification of neural crest and glial enhancers at the mouse Sox10 locus through transgenesis in zebrafish. PLoS Genet (2008) 1.60
Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol Cell Biol (1998) 1.59
Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease. Proc Natl Acad Sci U S A (2009) 1.56
Primary anorectal melanoma: an update. J Cancer (2012) 1.55
Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet (2007) 1.54
Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol (2012) 1.48
Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol (2010) 1.48
Enteric nervous system development: migration, differentiation, and disease. Am J Physiol Gastrointest Liver Physiol (2013) 1.46
Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res (2010) 1.38
Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J Clin Invest (2000) 1.37
Development and developmental disorders of the enteric nervous system. Nat Rev Gastroenterol Hepatol (2012) 1.36
Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res (2008) 1.35
SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc Natl Acad Sci U S A (2007) 1.32
An evolutionarily conserved intronic region controls the spatiotemporal expression of the transcription factor Sox10. BMC Dev Biol (2008) 1.31
Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb. Proc Natl Acad Sci U S A (2003) 1.30
Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol Cell Biol (2002) 1.30
Idiopathic weight reduction in mice deficient in the high-mobility-group transcription factor Sox8. Mol Cell Biol (2001) 1.28
Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol Cell Biol (1998) 1.28
Sox10-Venus mice: a new tool for real-time labeling of neural crest lineage cells and oligodendrocytes. Mol Brain (2010) 1.27
Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am J Hum Genet (2000) 1.26
Genetic basis of Hirschsprung's disease. Pediatr Surg Int (2009) 1.25
Mice null for sox18 are viable and display a mild coat defect. Mol Cell Biol (2000) 1.24
Building a brain in the gut: development of the enteric nervous system. Clin Genet (2012) 1.21
Sox6 is a candidate gene for p100H myopathy, heart block, and sudden neonatal death. Proc Natl Acad Sci U S A (2000) 1.21
The Yin and Yang of Sox proteins: Activation and repression in development and disease. J Neurosci Res (2009) 1.20
A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy. Hum Mol Genet (2008) 1.16
At the speed of sound: gene discovery in the auditory system. Am J Hum Genet (2001) 1.15
colgate/hdac1 Repression of foxd3 expression is required to permit mitfa-dependent melanogenesis. Dev Biol (2007) 1.14
Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. Am J Hum Genet (2013) 1.14
Sox8 is a critical regulator of adult Sertoli cell function and male fertility. Dev Biol (2008) 1.13
Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical features. Am J Hum Genet (2001) 1.11
Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness. Am J Hum Genet (2005) 1.10
A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet (2002) 1.09
The developmental etiology and pathogenesis of Hirschsprung disease. Transl Res (2013) 1.09
c-Ret-mediated hearing loss in mice with Hirschsprung disease. Proc Natl Acad Sci U S A (2010) 1.07
Comparison of melanoblast expression patterns identifies distinct classes of genes. Pigment Cell Melanoma Res (2009) 1.07
Greglist: a database listing potential G-quadruplex regulated genes. Nucleic Acids Res (2007) 1.07
Genetic background impacts developmental potential of enteric neural crest-derived progenitors in the Sox10Dom model of Hirschsprung disease. Hum Mol Genet (2010) 1.06
SOX10 directly modulates ERBB3 transcription via an intronic neural crest enhancer. BMC Dev Biol (2011) 1.03
Dual lineage-specific expression of Sox17 during mouse embryogenesis. Stem Cells (2012) 1.03
Cooperative binding of Sox10 to DNA: requirements and consequences. Nucleic Acids Res (2002) 1.03
Gpnmb is a melanoblast-expressed, MITF-dependent gene. Pigment Cell Melanoma Res (2008) 1.02
Cloning and characterisation of the Sry-related transcription factor gene Sox8. Nucleic Acids Res (2000) 1.01
Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia (2005) 1.01
Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. Br J Cancer (2013) 1.00
Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis. Dev Biol (2010) 1.00
Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease. Gut (2001) 0.99
Genetic interactions and modifier genes in Hirschsprung's disease. World J Gastroenterol (2011) 0.99
Interspecies difference in the regulation of melanocyte development by SOX10 and MITF. Proc Natl Acad Sci U S A (2006) 0.99
Developmental biology of the enteric nervous system: pathogenesis of Hirschsprung's disease and other congenital dysmotilities. Semin Pediatr Surg (2004) 0.98
A phenotype-driven ENU mutagenesis screen identifies novel alleles with functional roles in early mouse craniofacial development. Genesis (2011) 0.98
Human hereditary hearing impairment: mouse models can help to solve the puzzle. Hum Genet (2008) 0.96
The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen identified in a patient with a dramatic response to immunotherapy. Cancer Res (2002) 0.96
The armadillo repeat-containing protein, ARMCX3, physically and functionally interacts with the developmental regulatory factor Sox10. J Biol Chem (2009) 0.95
Association study of PHOX2B as a candidate gene for Hirschsprung's disease. Gut (2003) 0.94
Genetic background strongly modifies the severity of symptoms of Hirschsprung disease, but not hearing loss in rats carrying Ednrb(sl) mutations. PLoS One (2011) 0.94
Transcription factor Sox10 orchestrates activity of a neural crest-specific enhancer in the vicinity of its gene. Nucleic Acids Res (2011) 0.93
Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome? Am J Med Genet A (2008) 0.93
Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation. BMC Genomics (2008) 0.92
Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermatoendocrinol (2013) 0.92
The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10. Development (2011) 0.92
GnRH, anosmia and hypogonadotropic hypogonadism--where are we? Front Neuroendocrinol (2014) 0.92
Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol (2015) 0.92
Involvement of SOX10 in the pathogenesis of Hirschsprung disease: report of a truncating mutation in an isolated patient. J Mol Med (Berl) (2010) 0.90
Oligodendroglial and pan-neural crest expression of Cre recombinase directed by Sox10 enhancer. Genesis (2009) 0.89
A novel missense mutation of the paired box 3 gene in a Turkish family with Waardenburg syndrome type 1. Mol Vis (2013) 0.89
A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3-q32.3. J Med Genet (2006) 0.88
Congenital hearing impairment. Pediatr Radiol (2006) 0.88
A Sox10 expression screen identifies an amino acid essential for Erbb3 function. PLoS Genet (2008) 0.87
A zebrafish model for Waardenburg syndrome type IV reveals diverse roles for Sox10 in the otic vesicle. Dis Model Mech (2008) 0.87
SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter. Mol Cell Neurosci (2011) 0.86
Origins of gliogenic stem cell populations within adult skin and bone marrow. Stem Cells Dev (2010) 0.86
SoxE proteins are differentially required in mouse adrenal gland development. Mol Biol Cell (2008) 0.85
Investigation of germline GFR alpha-1 mutations in Hirschsprung disease. J Med Genet (1999) 0.85
Fine mapping of the NRG1 Hirschsprung's disease locus. PLoS One (2011) 0.85
Mechanisms for reaching the differentiated state: Insights from neural crest-derived melanocytes. Semin Cell Dev Biol (2008) 0.84
PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1. Mol Vis (2010) 0.84
Peroxisome-proliferator-activated receptor-binding protein (PBP) is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression. Biochem J (2009) 0.84
The microenvironment in the Hirschsprung's disease gut supports myenteric plexus growth. Int J Colorectal Dis (2012) 0.84
Fine mapping of the 9q31 Hirschsprung's disease locus. Hum Genet (2010) 0.83
Brain connexins in demyelinating diseases: therapeutic potential of glial targets. Brain Res (2012) 0.83
Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET. Pediatr Surg Int (2008) 0.83
Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II. Hum Genet (2011) 0.82
Molecular Study of Three Lebanese and Syrian Patients with Waardenburg Syndrome and Report of Novel Mutations in the EDNRB and MITF Genes. Mol Syndromol (2011) 0.81
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res (1989) 15.35
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res (1990) 8.52
Methylmercury poisoning in Iraq. Science (1973) 6.84
Overview of the National Infant Mortality Surveillance (NIMS) project--design, methods, results. Public Health Rep (1987) 5.66
Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation. Nature (2000) 5.52
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet (1997) 4.92
Autotrophic picoplankton in the tropical ocean. Science (1983) 4.80
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet (2006) 4.64
The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev (2001) 4.40
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet (1994) 4.11
Aortic homograft valve replacement. A long-term follow-up of an initial series of 101 patients. Circulation (1969) 4.10
Xwnt11 is a target of Xenopus Brachyury: regulation of gastrulation movements via Dishevelled, but not through the canonical Wnt pathway. Development (2000) 4.06
Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02
Sox10, a novel transcriptional modulator in glial cells. J Neurosci (1998) 3.96
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature (1994) 3.87
In utero antiepileptic drug exposure: fetal death and malformations. Neurology (2006) 3.64
Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature (1992) 3.63
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.46
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37
SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J Biol Chem (1999) 3.35
Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.33
Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate. Nature (1990) 3.27
DNA analysis in the diagnosis of hemoglobin disorders. Methods Enzymol (1981) 3.15
Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr (1997) 3.14
Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci U S A (1988) 3.11
The pathology of human aortic valve homografts. Thorax (1967) 3.01
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet (1994) 2.99
Homology and concerted evolution at the alpha 1 and alpha 2 loci of human alpha-globin. Nature (1981) 2.97
Lung cancer mortality and smoking habits: Mexican-American women. Am J Public Health (1982) 2.85
Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int (2000) 2.85
Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13, and alpha 1-acid glycoprotein to chromosome 9. Hum Genet (1986) 2.84
Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet (1999) 2.77
Models of respiratory rhythm generation in the pre-Bötzinger complex. I. Bursting pacemaker neurons. J Neurophysiol (1999) 2.76
Non-inactivation of an x-chromosome locus in man. Science (1979) 2.74
Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron (2001) 2.71
Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A (1999) 2.70
Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest (1998) 2.68
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68
Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet (2000) 2.63
Triplicated alpha-globin loci in humans. Proc Natl Acad Sci U S A (1980) 2.61
Molecular cloning and complete primary sequence of human erythrocyte porphobilinogen deaminase. Nucleic Acids Res (1986) 2.56
Mutant WD-repeat protein in triple-A syndrome. Nat Genet (2000) 2.54
Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. Neurology (2002) 2.53
A 3.5 genome equivalent multi access YAC library: construction, characterisation, screening and storage. Nucleic Acids Res (1990) 2.51
Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein. Br J Obstet Gynaecol (1980) 2.50
Neuronal pacemaker for breathing visualized in vitro. Nature (1999) 2.49
New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J (1999) 2.47
Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med (1989) 2.45
19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation. J Med Genet (2009) 2.37
Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol (1995) 2.36
Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell (1992) 2.34
Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet (2001) 2.32
Thermodynamic stability of water molecules in the bacteriorhodopsin proton channel: a molecular dynamics free energy perturbation study. Biophys J (1996) 2.30
Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron (1990) 2.30
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci (1992) 2.29
Influenza virus messenger RNAs are incomplete transcripts of the genome RNAs. Nucleic Acids Res (1977) 2.26
Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature (1991) 2.25
Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet (2005) 2.24
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23
Models of respiratory rhythm generation in the pre-Bötzinger complex. II. Populations Of coupled pacemaker neurons. J Neurophysiol (1999) 2.23
Consanguinity and complex cardiac anomalies with situs ambiguus. Arch Dis Child (1984) 2.21
Urinary tract in schoolgirls with covert bacteriuria. Arch Dis Child (1975) 2.21
Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet (1997) 2.20
Plasma-zinc in health and disease. Lancet (1970) 2.20
Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development (2001) 2.20
Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development. Development (1992) 2.19
Nodal-related signals induce axial mesoderm and dorsalize mesoderm during gastrulation. Development (1995) 2.16
Cellular mechanisms underlying modulation of breathing pattern in mammals. Ann N Y Acad Sci (1989) 2.16
Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci U S A (1998) 2.15
Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem (1998) 2.15
The role of dynamics in enzyme activity. Annu Rev Biophys Biomol Struct (2002) 2.14
Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat. J Physiol (1991) 2.14
Inhibition of Xbra transcription activation causes defects in mesodermal patterning and reveals autoregulation of Xbra in dorsal mesoderm. Development (1996) 2.13
Analgesic use and chronic renal disease. N Engl J Med (1989) 2.12
Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol (2000) 2.11